Subscribe to RSS
DOI: 10.1055/s-0030-1258577
Synthesis of 6-(1,2,3-Triazoloalkyl)-α-Pyrones by a Cascade RCM/CM and Click Chemistry Sequence
Publication History
Publication Date:
23 September 2010 (online)
Abstract
A RCM/CM process followed by a further nucleophilic substitution allowed the formation of an azido pyrone which was implicated into a copper-catalyzed [3+2] cycloaddition with various alkynes. Among the different conditions tested, the use of copper(II) salts furnished the expected adducts in a range of 42-99% yield.
Key words
ring-closing metathesis - click chemistry - [3+2] cycloadditions - triazoles - tandem
- 1
de Fatima A.Modolo LV.Conegero LS.Pilli RA.Ferreira CV.Kohn LK.de Carvalho JE. Curr. Med. Chem. 2006, 13: 3371 - 2
Meragelman TL.Scuderio DA.Davis RE.Staudt LM.McCloud TG.Cardellina JH.Shoemaker RH. J. Nat. Prod. 2009, 72: 336 - 3
Mohapatra DK.Das PP.Reddy DS.Yadav JS. Tetrahedron Lett. 2009, 50: 5941 - 4
Reddy DK.Shekhar V.Reddy TS.Reddy SP.Venkateswarlu Y. Tetrahedron: Asymmetry 2009, 20: 2315 - 5
Redipalli G.Venkataiah M.Fadnavis NW. Tetrahedron: Asymmetry 2010, 21: 320 - 6
Virolleaud MA.Bressy C.Piva O. Tetrahedron Lett. 2003, 44: 8081 - 7
Virolleaud MA.Piva O. Synlett 2004, 2087 - 8
Cros F.Pelotier B.Piva O. Eur J. Org. Chem. 2010, in press -
9a
Grubbs RH.Chang S. Tetrahedron 1998, 54: 4413 -
9b
Fürstner A. Angew. Chem. Int. Ed. 2000, 39: 3012 -
9c
Schrock RR.Hoveyda AH. Angew. Chem. Int. Ed. 2003, 42: 4592 -
9d
Boeda FH.Clavier H.Nolan SP. Chem. Commun. 2008, 2726 - For other applications of RCM/CM of trienes in synthesis, see:
-
10a
Quinn KJ.Isaacs AK.Arvary RA. Org. Lett. 2004, 6: 4143 -
10b
Quinn KJ.Isaacs AK.DeChristopher BA.Szklarz SC.Arvary RA. Org. Lett. 2005, 7: 1243 -
10c
Quinn KJ.Smith AG.Cammarano CM. Tetrahedron 2007, 63: 4881 -
10d
Riache N.Blond A.Nay B. Tetrahedron 2008, 64: 10853 -
10e
Enquist JA.Stoltz BM. Nature (London) 2008, 453: 1228 -
10f
Crimmins MT.Jacobs DL. Org. Lett. 2009, 11: 2695 -
10g
Quinn KJ.Curto JM.McGrath KP.Biddick NA. Tetrahedron Lett. 2009, 50: 7121 -
11a
Tomoe CW.Christensen C.Meldal M. J. Org. Chem. 2002, 67: 3057 -
11b
Rostovtsev VV.Green LG.Fokin VV.Sharpless KB. Angew. Chem. Int. Ed. 2002, 41: 2596 - 12
Bock VD.Hiemstra H.van Maarseveen JH. Eur. J. Org. Chem. 2006, 51 -
13a
Bock VD.Speijer D.Hiemstra H.van Maarseveen JH. Org. Biomol. Chem. 2007, 5: 971 -
13b
Hartwig S.Hecht S. Macromolecules 2010, 43: 242 - 14
Bressy C.Bargiggia F.Guyonnet M.Arseniyadis S.Cossy J. Synlett 2009, 565 -
15a
Ono K.Nagata T.Nishida A. Synlett 2003, 1207 -
15b
Young DGJ.Burlison JA.Peters U. J. Org. Chem. 2003, 68: 3494 -
15c
Rosillo M.Casarrubios L.Dominguez G.Pérez-Castells J. Org. Biomol. Chem. 2003, 1: 1450 -
15d
Geng X.Danishefsky SJ. Org. Lett. 2004, 6: 413 -
15e
Yang ZG.Geng X.Solit D.Pratilas CA.Rosen N.Danishesfsky SJ. J. Am. Chem. Soc. 2004, 126: 7881 -
15f
Ortega N.Martin T.Martin VS. Org. Lett. 2006, 8: 871 - 16
Pirrung MC.Biswas G.Ibarra-Rivera TR. Org. Lett. 2010, 12: 2402 -
17a
Metathesis
in Natural Product Synthesis
Cossy J.Arseniyadis S.Meyer C. Wiley-VCH; Weinheim: 2010. -
17b
Grubbs RH. Tetrahedron 2004, 60: 7117 -
17c
Connon SJ.Blechert S. Angew. Chem. Int. Ed. 2003, 42: 1900 -
18a
Schilling C.Jung N.Bräse S. In Organic Azides, Syntheses and ApplicationsBräse S.Banert K. Wiley; Chichester: 2010. p.269-284 -
18b
Holub JM.Kirschenbaum K. Chem. Soc. Rev. 2010, 39: 1325 -
18c
Amblard F.Cho JH.Schinazi RF. Chem. Rev. 2009, 109: 4207 -
18d
Gil MV.Arévalo MJ.Lopez O. Synthesis 2007, 1589 - 19
Davies MB. Polyhedron 1992, 11: 285 - 20
Brotherton WS.Michaels HA.Simmons JT.Clark RJ.Dalal NS.Zhu L. Org. Lett. 2009, 11: 4954 -
21a
Sevin A.Chodkiewicz W.Cadiot P. Tetrahedron Lett. 1965, 1953 -
21b
Bohlmann F.Schönowsky W.Inhoffen E.Grau G. Chem. Ber. 1964, 97: 794 -
22a
Tsubuki M.Knai K.Nagase H.Honda T. Tetrahedron 1999, 55: 2493 -
22b
Binder JT.Kirsch SF. Chem. Commun. 2007, 4164 -
22c
Menz H.Kirsch SF. Org. Lett. 2009, 11: 5634
References and Notes
Tandem RCM/CM Process: A solution of ester 3 (250 mg, 1.5 mmol) and 4-bromobutene (0.45 mL, 4.3 mmol) in CH2Cl2 (150 mL) was deoxygenated by bubbling argon for 10 min. Grubbs’ II catalyst (2; 32 mg, 0.04 mmol) was added at once and the resulting solution was heated at 40 ˚C until complete disappearance of the starting material (TLC control). The solution was concentrated and purified by flash chromatography on silica leading to 4 as a colorless oil. Compound 4: ¹H NMR (300 MHz, CDCl3): δ = 2.48 (br t, J = 6.0 Hz, 2 H), 2.58 (br q, J = 6.0 Hz, 2 H), 3.03-3.05 (m, 2 H), 3.38 (t, J = 6.9 Hz, 2 H), 5.00-5.03 (m, 1 H), 5.33-5.60 (m, 2 H), 5.86 (br s, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 29.9, 32.2, 35.8, 38.5, 78.9, 121.8, 125.7, 126.3, 131.7, 168.8. IR: 701, 734, 972, 1073, 1226, 1267, 1380, 1738, 2923, 3034 cm-¹. HRMS: m/z [M] calcd for C10H13O2Br: 245.0177; found: 245.0177. Compound 5: ¹H NMR (300 MHz, CDCl3): δ = 2.29-2.38 (m, 2 H), 2.46-2.50 (m, 2 H), 3.03-3.05 (m, 2 H), 3.29 (t, J = 6.8 Hz, 2 H), 4.98-5.03 (m, 1 H), 5.55-5.60 (m, 2 H), 5.84-5.87 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 30.0, 32.2, 38.7, 50.8, 79.0, 122.0, 125.8, 126.4, 131.0, 168.8. IR: 701, 734, 972, 1073, 1226, 1267, 1380, 1738, 2923, 3034 cm-¹. HRMS: m/z [M + H+] calcd for C10H14O2N3: 208.1086; found: 208.1085.
24Compound 7a: ¹H
NMR (300 MHz, CDCl3): δ = 2.37-2.63 (m,
2 H), 2.65-2.93 (m, 2 H), 2.93-2.95 (m, 2 H),
4.40-4.46 (m, 2 H), 4.89-4.92 (m, 1 H), 5.41-5.60
(m, 2 H), 5.67-5.79 (m, 2 H), 7.29-7.35 (m, 1
H), 7.39-7.44 (m, 2 H), 7.76 (s, 1 H), 7.79-7.83
(m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 29.7,
33.2, 38.3, 49.7, 78.5, 122.0, 121.8, 125.4, 127.1, 127.9, 128.6,
129.5, 130.5, 145.2, 147.2, 168.8. IR: 732, 911, 1049, 1076, 1226,
1382, 1736, 2925, 3136 cm-¹. HRMS:
m/z [M + Na+] calcd
for C18H19O2N3: 332.1375;
found: 332.1375. Compound 7b: ¹H
NMR (300 MHz, CDCl3): δ = 0.91 (t, J = 7.1 Hz, 3 H), 1.36 (sext, J = 7.1 Hz, 2 H), 1.63 (quint, J = 7.1 Hz, 2 H), 2.38-2.43
(m, 2 H), 2.56-2.62 (m, 2 H), 2.69 (t, J = 7.1
Hz, 2 H), 2.99-3.03 (m, 2 H), 4.33 (td, J = 6.8,
2.2 Hz, 2 H), 4.91-4.94 (m, 1 H), 5.40-5.56 (m,
2 H), 5.71-5.89 (m, 2 H), 7.28 (s, 1 H). ¹³C
NMR (75 MHz, CDCl3): δ = 13.8, 22.3,
25.3, 29.9, 31.6, 33.5, 38.6, 49.7, 78.8, 120.8, 122.0, 125.7, 127.1,
128.8, 130.0, 168.8. IR: 1049, 1225, 1379, 1735, 2930, 3042 cm-¹.
HRMS: m/z [M + H+] calcd
for C16H24O2N3: 290.1869;
found: 290.1869. Compound 7c: ¹H
NMR (300 MHz, CDCl3): δ = 0.57 (td,
J = 7.0, 2.3 Hz, 3 H), 0.95
(br s, 12 H), 1.27 (t, J = 6.9
Hz, 2 H), 2.04-2.17 (m, 2 H), 2.28-2.39 (m, 2
H), 2.70 (d, J = 3.6 Hz, 2 H),
3.20 (t, J = 6.8 Hz, 2 H), 4.05-4.09
(m, 2 H), 4.29 (s, 2 H), 4.62-4.66 (m, 1 H), 5.11-5.28
(m, 2 H), 5.43-5.48 (m, 1 H), 5.52-5.58 (m, 1
H), 7.26 (s, 1 H). ¹³C NMR (75 MHz,
CDCl3): δ = 14.0, 22.5, 26.0, 29.1,
29.3, 29.4, 29.5, 29.8, 31.7, 33.3, 38.4, 49.6, 64.1, 70.7, 78.6,
121.9, 122.4, 125.6, 127.2, 129.7, 145.2, 168.7. IR: 703, 816, 973,
1049, 1097, 1223, 1378, 1462, 1739, 2855, 2926 cm-¹.
HRMS:
m/z [M + Na+] calcd
for C22H35O3N3: 412.2571;
found: 412.2564. Compound 7d: ¹H
NMR (300 MHz, CDCl3): δ = 2.27-2.47
(m, 2 H), 2.70-2.59 (m, 2 H), 3.00 (m, 2 H), 3.91 (s, 3
H), 4.40-4.46 (m, 2 H), 4.87-4.97 (m, 1 H), 5.37-5.56 (m,
2 H), 5.68-5.73 (m, 1 H), 5.79-5.84 (m, 1 H),
8.08 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 29.9,
33.2, 38.4, 50.1, 52.1, 78.6, 122.1, 125.6, 127.6, 127.9, 129.1,
139.7, 161.1, 168.8. IR: 2952, 1735, 1543, 1435, 1370, 1228, 1161,
1046, 974, 809, 777, 701 cm-¹. HRMS: m/z [M + Na+] calcd
for C14H17O4N3: 314.1111;
found: 314.1103. Compound 7e: ¹H NMR
(300 MHz, CDCl3): δ = 0.29 (s, 9 H),
2.37-2.42 (m, 2 H), 2.57-2.70 (m, 2 H), 2.98-3.01
(m, 2 H), 4.36-4.44 (m, 2 H), 4.88-4.93 (m, 1
H), 5.46-5.56 (m, 2 H), 5.69-5.75 (m, 1 H), 5.79-5.86
(m, 1 H), 7.51 (s, 1 H). ¹³C NMR (75
MHz, CDCl3): δ = -1.0, 29.9,
33.6, 38.6, 49.3, 78.8, 121.9, 125.7, 127.1, 129.1, 129.9, 146.4,
168.8. IR: 701, 760, 843, 973, 1050, 1194, 1249, 1379, 1739, 2956
cm-¹. HRMS: m/z [M + Na+] calcd
for C15H23O2N3Si: 328.1452;
found: 328.1442.
Compound 8a: ¹H
NMR (300 MHz, CDCl3): δ = 2.12-2.18 (m,
2 H), 2.31-2.46 (m, 2 H), 2.65-2.71 (m, 2 H),
4.27-4.36 (m, 1 H), 4.46 (t, J = 6.7
Hz, 2 H), 5.43-5.62 (m, 2 H), 5.90 (dt, J = 9.7,
1.8 Hz, 1 H), 6.68 (dt, J = 9.7,
4.3 Hz, 1 H),7.30-7.35 (m, 1 H), 7.39-7.44 (m,
2 H), 7.77 (s, 1 H), 7.81-7.85 (m, 2 H). ¹³C
NMR (75 MHz, CDCl3): δ = 28.6, 33.5,
37.7, 50.0, 77.1, 121.2, 125.7, 128.2, 128.3, 128.9, 129.1, 129.2, 130.6,
145.1, 147.1, 164.3. IR: 731, 909, 1047, 1227, 1386, 1731, 2924,
3031 cm-¹. HRMS: m/z [M + H+] calcd
for C18H20O2N3: 310.1555;
found: 310.1555. Compound 8b: ¹H NMR
(300 MHz, CDCl3): δ = 0.92 (t, J = 7.0 Hz, 3 H), 1.37 (sext., J = 7.8 Hz, 2 H), 1.63 (quint, J = 7.8 Hz, 2 H), 2.19-2.23
(m, 2 H), 2.32-2.47 (m, 2 H), 2.57-2.63 (m, 2
H), 2.68 (t, J = 7.8 Hz, 2 H),
4.36 (t, J = 6.8 Hz, 2 H), 4.28-4.41
(m, 1 H), 5.46-5.50 (m, 2 H), 6.00 (dt, J = 9.8
Hz, 1.9 Hz, 1 H), 6.86 (dt, J = 9.8,
4.5 Hz, 1 H), 7.27 (s, 1 H). ¹³C NMR
(75 MHz, CDCl3): δ = 13.8, 22.2, 25.3,
28.5, 31.6, 33.4, 37.6, 49.6, 77.1, 120.6, 121.1, 127.7, 129.3,
145.2, 148.3, 164.2. IR: 2955, 2929, 2858, 1719, 1550, 1459, 1433,
1387, 1249, 1148, 1133, 1043, 972, 816, 666 cm-¹.
HRMS: m/z [M + H+] calcd
for C16H24O2N3: 290.1863;
found: 290.1862. Compound 8c: ¹H
NMR (300 MHz, CDCl3): δ = 0.83 (t, J = 7.0 Hz, 3 H), 1.22 (br s,
12 H), 1.50-1.57 (m, 2 H), 2.13-2.29 (m, 2 H),
2.31-2.45 (m, 2 H), 2.56-2.67 (m, 2 H), 3.46 (t,
J = 6.8 Hz, 2 H),
4.30-4.41 (m, 1 H), 4.36 (t, J = 6.9
Hz, 2 H), 4.55 (s, 2 H), 5.39-5.56 (m, 2 H), 5.96 (d, J = 9.6 Hz, 1 H), 6.81-6.87
(m, 1 H), 7.52 (s, 1 H). ¹³C NMR (75
MHz, CDCl3): δ = 14.1, 22.7, 26.1,
28.6, 29.3, 29.5, 29.6, 29.7, 31.9, 33.4, 37.7, 49.9, 64.3, 71.0,
77.1, 121.2, 122.5, 128.0, 129.1, 145.2, 145.5, 164.3. IR: 666,
814, 971, 1044, 1097, 1245, 1382, 1429, 1459, 1720, 2851, 2926 cm-¹.
HRMS:
m/z [M + Na+] calcd
for C22H35O3N3: 412.2571;
found: 412.2566. Compound 8d: ¹H
NMR (300 MHz, CDCl3): δ = 2.18-2.27
(m, 2 H), 2.29-2.46 (m, 2 H), 2.61-2.75 (m, 2
H), 3.92 (s, 3 H), 4.35 (q, J = 6.2
Hz, 1 H), 4.46 (t, J = 7.0 Hz,
2 H), 5.40-5.64 (m, 2 H), 5.99 (d, J = 9.9
Hz, 1 H), 6.81-6.87 (m, 1 H), 8.08 (s, 1 H). ¹³C
NMR (75 MHz, CDCl3): δ = 28.6, 33.3,
37.6, 50.2, 52.2, 77.0, 121.2, 127.6, 127.7, 128.6, 128.6, 145.2,
161.1, 164. 2. IR: 778, 815, 1044, 1207, 1231, 1248, 1366, 1387,
1435, 1543, 1720, 2917, 2950 cm-¹. HRMS: m/z [M + Na+] calcd
for C14H17O4N3: 314.1111; found:
314.1106. Compound 8e: ¹H
NMR (300 MHz, CDCl3): δ = 0.28 (s,
9 H), 2.17-2.22 (m, 2 H), 2.25-2.47 (m, 2 H),
2.57-2.69 (m, 2 H), 4.30-4.43 (m, 1 H), 4.40 (t, J = 6.9 Hz, 2 H), 5.45-5.50
(m, 2 H), 5.97 (dt, J = 9.6,
1.7 Hz, 1 H), 6.81-6.87 (m, 1 H), 7.50 (s, 1 H). ¹³C
NMR (75 MHz, CDCl3): δ = -1.0,
28.7, 33.6, 37.8, 49.3, 77.2, 121.3, 127.8, 127.9, 129.0, 129.3,
145.2, 146.6, 164.3. IR: 655, 759, 816, 843, 972, 1043, 1116, 1146,
1194, 1249, 1387, 1424, 1490, 1719, 2851, 2917, 2955 cm-¹.
HRMS: m/z [M + Na+] calcd for
C15H23O2N3Si: 328.1452;
found: 328.1440.